SCHEMBL514096

SCHEMBL514096

CCOC(=O)N(c1ccccc1CN1CCOCC1=O)S(=O)(=O)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 2/20 0.37
GCK P35557 1/20 0.34
PDK2 Q15119 1/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
RORC P51449 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
POLB P06746 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
PER2 O15055 1/20 0.32
EPHX2 P34913 1/20 0.32
AOC2 O75106 1/20 0.32
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1967282 0.85 KMT2A (0.39) KDM4EALDH1A1POLBMEN1KMT2A
SCHEMBL514316 0.84 ALDH1A1 (0.34) CMA1KDM4EALDH1A1NPC1RAB9A
SCHEMBL514567 0.83 ALDH1A1 (0.33) KDM4EALDH1A1POLBSLC6A2SLC6A4
SCHEMBL514794 0.83 ALDH1A1 (0.33) KDM4EALDH1A1POLBSLC6A2SLC6A4
SCHEMBL1964874 0.83 ALDH1A1 (0.34) KDM4EALDH1A1NPC1RAB9APOLB
SCHEMBL1966626 0.83 ALDH1A1 (0.37) KDM4EALDH1A1NPC1SLC6A2SLC6A4
SCHEMBL16862452 0.80 KDM4E (0.34) KDM4EALDH1A1POLBSLC6A2SLC6A4
SCHEMBL513789 0.80 ALDH1A1 (0.31) KDM4EALDH1A1POLBSLC6A2SLC6A4
SCHEMBL16862460 0.79 ALDH1A1 (0.38) KDM4EALDH1A1SLC6A2SLC6A4SLC6A3
SCHEMBL16862449 0.78 ALDH1A1 (0.38) KDM4EALDH1A1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 CMA1 1530/4885GCK 2027/4885PDK2 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.